omeprazole and nizatidine

omeprazole has been researched along with nizatidine in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.70)18.7374
1990's13 (35.14)18.2507
2000's19 (51.35)29.6817
2010's4 (10.81)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, CY; Chen, LT; Jan, CM; Perng, DS; Wang, WM1
Guram, M; Holt, S; Howden, CW1
Gardner, JD; Jensen, RT; Maton, PN1
Castell, DO; Just, RJ; Lagerström, PO; Leite, LP1
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ1
Cosentino, S; Giannone, N; Lanzafame, S; Magnano, A; Russo, A1
Chijiiwa, Y; Maruoka, A; Nawata, H; Tanaka, M1
Brummer, RJ; Stockbrügger, RW1
Berstad, A; Hatlebakk, JG1
Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K1
Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH1
Bertaccini, G; Coppelli, G; Coruzzi, G; Frati, P1
Itoh, M; Joh, T; Kurokawa, T; Sasakii, M; Seno, K; Tsuchida, K; Yokoyama, Y1
Furuta, S; Kamada, E; Kawabata, Y; Sano, H; Shinozaki, Y; Sugimoto, T; Suzuki, T1
Armstrong, D; Paré, P; Pericak, D; Pyzyk, M2
Andersen, LP; Chen, M; Colding, H; Jensen, B; Kharazmi, A; Kristiansen, JE; Zhai, L1
Bochenek, W; DeVault, K; Kovacs, TO; Miska, D; Wilcox, CM1
El-Serag, HB; El-Zimaity, HM; Graham, DY; Hammoud, F; Kim, JG; Osato, MS1
Armstrong, D; Goeree, R; Meyer, F; Paré, P; Pericak, D; Pyzyk, M1
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, JH; Sullivan, TJ1
Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Watanabe, K1
Bochenek, WJ; Fraga, PD; Mack, ME; Metz, DC1
Akimoto, M; Hashimoto, H; Maeda, A; Shigemoto, M; Yamashita, K1
Esplugues, JV; Martí-Cabrera, M; Ponce, J1
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B1

Reviews

6 review(s) available for omeprazole and nizatidine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Gastroenterology clinics of North America, 1989, Volume: 18, Issue:4

    Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome

1989
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Clinical pharmacokinetics, 1996, Volume: 31, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides

1996
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2003, May-15, Volume: 17, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors

2003
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Alimentary pharmacology & therapeutics, 2004, Nov-15, Volume: 20, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Randomized Controlled Trials as Topic; Sulfoxides; Treatment Outcome

2004
[Safety of proton pump inhibitors].
    Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors

2006

Trials

9 trial(s) available for omeprazole and nizatidine

ArticleYear
Histologic patterns of omeprazole and nizatidine-healed duodenal ulcers:accuracy of endoscopic diagnosis.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 206

    Topics: Adult; Biopsy; Duodenal Ulcer; Duodenoscopy; Humans; Intestinal Mucosa; Middle Aged; Nizatidine; Omeprazole

1994
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1997, Volume: 59, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates

1997
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Multivariate Analysis; Nizatidine; Omeprazole; Patient Dropouts; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Treatment Outcome

1999
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

2001
Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Severity of Illness Index; Sulfoxides; Treatment Outcome

2002
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2003, May-15, Volume: 17, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors

2003
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Canada; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Reproducibility of Results; Self-Assessment; Severity of Illness Index; Sulfoxides; Surveys and Questionnaires; Treatment Outcome

2003
Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
    Journal of clinical gastroenterology, 2003, Volume: 37, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Gastroesophageal Reflux; Health Status Indicators; Heartburn; Humans; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Sulfoxides; Treatment Outcome

2003
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
    Journal of gastroenterology, 2003, Volume: 38, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Breath Tests; Carbon Radioisotopes; Dose-Response Relationship, Drug; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Time Factors; Treatment Outcome; Urea

2003

Other Studies

23 other study(ies) available for omeprazole and nizatidine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Comparison of omeprazole and nizatidine in the treatment of duodenal ulcers.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1992, Volume: 91, Issue:8

    Topics: Adult; Aged; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Nizatidine; Omeprazole

1992
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
    Alcoholism, clinical and experimental research, 1991, Volume: 15, Issue:6

    Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine

1991
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:10

    Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole

1995
Drug interactions of H2-receptor antagonists.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 206

    Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline

1994
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Scandinavian journal of gastroenterology, 1994, Volume: 29, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Piperidines; Proton Pump Inhibitors; Stomach Ulcer; Ultrasonography, Interventional; Wound Healing

1994
Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:10

    Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Bacteria; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nizatidine; Omeprazole; Stomach

1996
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:5

    Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine

1998
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
    Pharmacological research, 1998, Volume: 38, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Drug Interactions; Gastric Acid; Lansoprazole; Male; Nizatidine; Omeprazole; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Sucralfate

1998
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.
    Xenobiotica; the fate of foreign compounds in biological systems, 2001, Volume: 31, Issue:1

    Topics: Anti-Ulcer Agents; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Male; Microsomes, Liver; Nizatidine; Omeprazole; Pharmaceutical Preparations

2001
Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Synergism; Drug Therapy, Combination; Electron Transport; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Nizatidine; Omeprazole

2002
Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:4

    Topics: Adult; Analysis of Variance; Anti-Ulcer Agents; Anticonvulsants; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Male; Nizatidine; Omeprazole; Phenytoin

1993
Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.
    Journal of gastroenterology, 2005, Volume: 40, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Base Sequence; Benzimidazoles; Biopsy, Needle; Case-Control Studies; Female; Gastric Mucosa; Gastroscopy; Humans; Immunohistochemistry; Male; Middle Aged; Molecular Sequence Data; Neovascularization, Physiologic; Nizatidine; Omeprazole; Polymerase Chain Reaction; Probability; Rabeprazole; Receptors, CXCR4; Reference Values; Risk Assessment; RNA, Messenger; Severity of Illness Index; Stomach Ulcer; Wound Healing

2005
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays

2012